Kinase fusions have been identified in distinct histological subtypes of thyroid cancer, including papillary thyroid cancer (PTC; RET, NTRK1/2/3), medullary thyroid cancer (ALK), and poorly differentiated thyroid cancer (RET, ALK) (5,9,10). The gene discussed is ALK; the disease is thyroid gland carcinoma.